TLRY - Tilray Brands, Inc. Stock Analysis | Stock Taper
Logo
Tilray Brands, Inc.

TLRY

Tilray Brands, Inc. NASDAQ
$7.87 -1.50% (-0.12)

Market Cap $796.82 M
52w High $23.20
52w Low $3.50
P/E -0.33
Volume 1.89M
Outstanding Shares 101.25M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2026 $303.85M $111.45M $-62.77M -20.66% $-0.57 $-26.03M
Q1-2026 $287.78M $76.07M $-442.31K -0.15% $-0 $29.51M
Q4-2025 $308.1M $2.07B $-1.75B -566.86% $-17.8 $-1.84B
Q3-2025 $268.34M $1.17B $-1.14B -424.93% $-12.6 $-1.08B
Q2-2025 $295.06M $144.68M $-119.37M -40.46% $-1.4 $-57.94M

What's going well?

Sales are still growing, with revenue up 6% from last quarter. Gross profit also edged up, showing the core business can generate cash if costs are controlled.

What's concerning?

Operating expenses surged much faster than sales, and the company swung to a big loss. Large 'other' expenses and a growing share count are hurting shareholders.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2026 $407.29M $2.93B $771.26M $2.21B
Q1-2026 $363.78M $2.86B $771.97M $2.12B
Q4-2025 $351.78M $2.9B $860.49M $2.07B
Q3-2025 $358.81M $4.92B $1.01B $3.94B
Q2-2025 $352.82M $5.86B $1.03B $4.86B

What's financially strong about this company?

The company has a solid liquidity position, with current assets nearly three times current liabilities. Most debt is long-term and equity is strongly positive, giving them a good foundation to weather short-term bumps.

What are the financial risks or weaknesses?

Retained earnings are deeply negative, showing years of losses. Over a third of assets are goodwill and intangibles, which could be written down if acquisitions disappoint. Cash is only slightly above net debt, so there isn't a huge safety margin.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2026 $-60.78M $-11.93M $-81.03M $67.19M $-25.32M $-25.47M
Q1-2026 $2.08M $-1.84M $33.61M $27.26M $59.29M $-14.92M
Q4-2025 $-1.75B $-19.86M $16.62M $26.12M $29.79M $-29.27M
Q3-2025 $-1.14B $-5.09M $2.2M $21.45M $14.82M $-24.81M
Q2-2025 $-119.37M $-56.72M $-14.81M $53.12M $-21.66M $-64.28M

What's strong about this company's cash flow?

The company still has a sizable cash balance of $345 million, giving it some breathing room. Non-cash charges make up most of the reported losses, so actual cash burn is less than the headline net loss.

What are the cash flow concerns?

Cash burn is rising, and the company is highly dependent on selling new shares to survive. Shareholder dilution is significant, and working capital is using up more cash each quarter.

Revenue by Products

Product Q3-2025Q4-2025Q1-2026Q2-2026
Beverage Alcohol Business
Beverage Alcohol Business
$60.00M $70.00M $60.00M $50.00M
Cannabis Segment
Cannabis Segment
$70.00M $90.00M $90.00M $90.00M
Distribution Revenue
Distribution Revenue
$60.00M $70.00M $70.00M $90.00M
Wellness Business
Wellness Business
$10.00M $20.00M $20.00M $10.00M

Revenue by Geography

Region Q3-2025Q4-2025Q1-2026Q2-2026
CANADA
CANADA
$50.00M $50.00M $60.00M $50.00M
E M E A
E M E A
$70.00M $90.00M $90.00M $100.00M
Rest of World
Rest of World
$0 $0 $0 $0
UNITED STATES
UNITED STATES
$60.00M $70.00M $60.00M $60.00M

Q2 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Tilray Brands, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Tilray’s main strengths are its growing revenue base, improving gross margins, and diversified business model that spans cannabis, beverages, wellness, and distribution across multiple geographies. It holds leading positions in several markets, including Canadian recreational cannabis, cannabis beverages, and European medical cannabis, and it has a notable foothold in U.S. craft beer. The balance sheet, while weakened, still shows acceptable liquidity and reduced debt levels, and capital spending has been kept under control. The company also benefits from meaningful experience navigating complex regulations and from a visible innovation agenda in cultivation technology and product development.

! Risks

The most significant risks are financial. Net losses, operating losses, and cash burn are all very large and have been worsening rather than improving, leading to sharply negative margins and a heavy reliance on equity issuance. Asset impairments and cumulative losses have severely eroded shareholder equity, and retained earnings are deeply negative. If losses and negative free cash flow persist, access to capital could become more difficult or more dilutive. Operationally, high overhead, reduced formal R&D investment, and the challenge of integrating and managing diverse businesses (cannabis, beverages, wellness) all add execution risk. Industry-specific risks—regulatory uncertainty, pricing pressure, and strong competition—further complicate the picture.

Outlook

The outlook for Tilray is highly dependent on two factors: its ability to bring costs under control and move toward sustainable positive cash flow, and how global cannabis and related regulations evolve, particularly in the United States. The company has built a strategic platform with real market presence and clear optionality if legalization trends continue, which creates upside potential if execution improves. However, current financial trends are unfavorable, and turning the business from a scale-driven growth story into a profitable, self-funding enterprise will likely require significant restructuring, discipline, and time. Overall, the strategic positioning is promising, but the financial and operational path to realizing that promise is challenging and uncertain.